Mechanistic first-in-human dosability screen for tumor-targeted bispecific antibodies — go/no-go and dosability-margin ranking computed from binding parameters, before any dose exists.
pharmacometrics drug-development immuno-oncology first-in-human-clinical-trial mabel quantitative-pharmacology pkpd-modelling ternary-complex bispecific-antibody dose-selection
-
Updated
Jul 2, 2026 - Python